OTC Switch For Naloxone Finding Interest Among Sponsors

Now that US FDA is about to complete label comprehension study, sponsors seem more positive about OTC versions of naloxone products.

The US FDA is actively recruiting sponsors of potential over-the-counter naloxone applications and signaled interest is high, although price and other concerns remain should the switch occur.

Offering OTC naloxone is one proposed method of increasing access to the rescue medication for opioid overdoses, which could help...

More from US FDA Performance Tracker

More from Regulatory Trackers